Terns Pharmaceuticals Competitors and Similar CompaniesClear all
Terns Pharmaceuticals's competitors and similar companies include Rigel Pharmaceuticals and Ncardia.
 Terns Pharmaceuticals Terns Pharmaceuticals is a biopharmaceutical company developing small-molecule single-agent and combination therapy for the treatment of non-alcoholic steatohepatitis and other chronic liver diseases. |  Rigel Pharmaceuticals Rigel Pharmaceuticals develops small-molecule drugs for the treatment of autoimmune diseases, cancer and metabolic diseases. | ||
Founding Date | Founding Date 2017 | Founding Date 1996 | Founding Date 2010 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Foster City, US HQ | Locations South San Francisco, US HQ | Locations Gosselies, BE HQ Leiden, NL |
Employees | Employees 59 | Employees 1633% increase | Employees 547% decrease |
Valuation ($) | Valuation ($) 580.9 m | Valuation ($) 256 m | Valuation ($) N/A |
Financial | |||
Net income | Net income ($96.2m) (FY, 2025) | Net income $367m (FY, 2025) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised $ 30m | Total funding raised $ 130m | Total funding raised $ 20.2m |
For sources of this data, please see the company profile
View Company Profiles
Rigel Pharmaceuticals
HQ
South San Francisco, US
Employees
163↑ 3% increase
Rigel Pharmaceuticals develops small-molecule drugs for the treatment of autoimmune diseases, cancer and metabolic diseases.
View company
Ncardia
HQ
Gosselies, BE
Employees
54↓ 7% decrease
Ncardia is a stem cell drug discovery and development company.
View company